Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 2529 - Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameMedicare Advisory Panel on Clinical Diagnostic Laboratory TestsAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number2529
Original Establishment Date7/1/2015Committee StatusChartered
Actual Termination Date Committee URLhttps://www.cms.gov/Regulations-and-Guidance/Gu...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*15
Current Charter Date4/26/2019Designated Fed Officer Position Title*DFO
Date Of Renewal Charter4/26/2021Designated Federal Officer PrefixDr.
Projected Termination Date Designated Federal Officer First Name*Rasheeda
Exempt From Renewal*NoDesignated Federal Officer Middle NameJameeka
Specific Termination AuthorityDesignated Federal Officer Last Name*Arthur
Establishment Authority*Statutory (Congress Created)Designated Federal Officer Suffix
Specific Establishment Authority*Section 1834A(f)(1) of the Social Security Act (the Act) (42 USC 1395m-1)Designated Federal Officer Phone*(410) 786-3434
Effective Date Of Authority*7/1/2015Designated Federal Officer Fax*410-786-0681
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*rasheeda.arthur@cms.hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*Regulatory Negotiations Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Panel may advise the Secretary of the Department of Health and Human Services (HHS), and the Administrator of the Centers for Medicare & Medicaid Services (CMS), on the following: 1) the establishment of payment rates under section 1834A of the Act for new clinical diagnostic laboratory tests, including whether to use cross-walking or gap-filling processes to determine payment for a specific new test; and 2) the factors used in determining coverage and payment processes for new clinical diagnostic laboratory tests. In addition, the Panel may provide recommendations to the Secretary of HHS and the Administrator of CMS under section 1834A of the Act.
How is membership balanced?*The Panel shall consist of up to 15 individuals with expertise in issues related to clinical diagnostic laboratory tests, which may include representatives of clinical laboratories, molecular pathologists, clinical laboratory researchers, and individuals with expertise in clinical laboratory science or health economics, with regard to issues related to the development, validation, performance, safety, and application of such tests. Members shall be appointed by the Secretary, or CMS Administrator, or CMS Administrator’s designee.
How frequent & relevant are cmte mtgs?*Estimated Number of Meetings per Year - 4. The Panel is relevant because it considers and advises on the following issues:•Calculation of weighted medians of private payor rates for laboratory tests.•Phase-in of reductions in Medicare payment rates based on private payor rates, as required.•Application of market rates to establishment of Medicare payment rates.•Evaluation and designation of tests as advanced diagnostic laboratory tests as defined in section 1834A of the Act.•Whether to use crosswalking or gapfilling to determine payment for a specific new test.•The factors used in determining coverage or payment processes for new clinical diagnostic laboratory tests.
Why advice can't be obtained elsewhere?*The Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests (the Panel) is required by law under section 1834A(f)(1) of the Social Security Act (42 U.S.C. 1395m-1) (the Act), as established by section 216 of Public Law 113-93, enacted April 1, 2014.
Why close or partially close meetings?Not Applicable
Recommendation Remarks
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*NoAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchNoAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNot Applicable
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNot ApplicableNumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNot ApplicableGrants Review CommentNot Applicable
Number Of Recommendations*531Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentApproximately 531 recommendations (45 rec in 2015 + 45 rec in 2016 + 117 rec in 2017+ 102 rec in 2018 + 90 rec in 2019 +132 rec in 2020) were generated for the life of the committee.Access Agency WebsiteYes
% of Recs Fully Implemented*85.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentApproximately 85 percent of the CDLT Panel recommendations are fully implemented by the Agency.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*10.00%Access PublicationsYes
% of Recs Partially Implemented CommentOf the 15 percent that are not fully implemented, approximately 10 percent are partially implemented. For the remaining 5 percent, CMS may not be able to address these issues due to statutory constraints, or they may be addressed in future years as we are able to do so.Access OtherNo
Agency Feedback*YesAccess CommentNot Applicable
Agency Feedback Comment*Panel recommendations are verified before they are made final and then posted on CMS website.Narrative Description*The Panel may advise the Secretary of the Department of Health and Human Services (HHS), and the Administrator of the Centers for Medicare & Medicaid Services (CMS), on the following: 1)the establishment of payment rates under section 1834A of the Act for new clinical diagnostic laboratory tests, including whether to use crosswalking or gapfilling processes to determine payment for a specific new test; and 2)the factors used in determining coverage and payment processes for new clinical diagnostic laboratory tests.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$179,638.11Estimated Payments to Federal Staff*$180,000.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$20,000.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$0.00Est. Other Costs Next FY*$600.00
Total Costs$179,638.11Est. Total Next FY*$200,600.00
Federal Staff Support (FTE)*1.45Est. Fed Staff Support Next FY*1.45
Cost RemarksEst Cost Remarks
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036542Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests2019
 COM-034754Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests2018
 COM-001729Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests2017
 COM-002298Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests2016
 COM-004147Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests2015